Enliven Therapeutics, Inc.ELVN
Close of Friday, October 23, 2026 · Enliven Therapeutics, Inc. is trading below its Pivot, OnlyAlpha's long-term trend line.
Price
$41.52
vs its Pivot
-1.8%
OnlyAlpha Score
36
Trend
Below its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| -8.1% | +169.6% | +102.6% | — | — |
No dividend in the last 12 months.
Who runs and owns it
In these funds
Big investors that own it (latest 13F)
| OrbiMed | 6.5% of holdings |
| Baker Bros. Advisors | 0.2% of holdings |
Get ELVN in your free daily emailAfter every close: whether ELVN is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track ELVN free → Full Stock check
Track ELVN free → Full Stock check